HPTN 083‐02: factors influencing adherence to injectable PrEP and retention in an injectable PrEP study

HPTN 083‐02: factors influencing adherence to injectable PrEP and retention in an injectable PrEP study

Abstract Introduction HPTN 083 demonstrated the superiority of long‐acting cabotegravir (CAB‐LA) versus daily oral emtricitabine/tenofovir disoproxil fumarate (TDF/FTC) as pre‐exposure prophylaxis (PrEP) among cisgender men and transgender women who have sex with men (MSM/TGW). HPTN 083 provided the...

Full description

Bibliographic Details
Main Authors: Christina Psaros, Georgia R. Goodman, Jasper S. Lee, Whitney Rice, Colleen F. Kelley, Temitope Oyedele, Lara E. Coelho, Nittaya Phanuphak, Yashna Singh, Keren Middelkoop, Sam Griffith, Marybeth McCauley, James Rooney, Alex R. Rinehart, Jesse Clark, Vivian Go, Jeremy Sugarman, Sheldon D. Fields, Adeola Adeyeye, Beatriz Grinsztejn, Raphael J. Landovitz, Steven A. Safren, the HPTN 083‐02 Study Team
Format: Article
Language:English
Published: Wiley 2024-05-01
Series:Journal of the International AIDS Society
Subjects:
HIV prevention
injectable PrEP
men who have sex with men
pre‐exposure prophylaxis
qualitative
transgender women
Online Access:https://doi.org/10.1002/jia2.26252

Internet

https://doi.org/10.1002/jia2.26252

Similar Items